Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio
Officinae Bio’s AI-driven sequence optimization expands Maravai’s family of brands, enabling rapid, cost-effective nucleic acid therapy development SAN DIEGO–(BUSINESS WIRE)– Maravai LifeSciences, Inc. (NASDAQ: MRVI),...